CeQur is dedicated to helping people with type 2 diabetes manage their disease. They have developed an insulin infuser that is easily integrated into patients’ lives.

The company’s lead product, PAQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for three days at a time. The insulin infuser includes a disposable insulin reservoir that is connected to a reusable electronic messenger. This messenger tells the wearer when to replace the insulin reservoir.

CeQur has completed clinical studies evaluating PAQ among people with type 2 diabetes with positive results. PAQ obtained its CE mark in 2012.